Obstructive Sleep Apnea News and Research

RSS

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep.

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Circadiance, the leader in soft-cloth nasal CPAP masks, announces the new Zzzephyr Seal, a revolutionary elastic cloth seal designed to fit more comfortably over the patient's nose. The lightweight seal reduces air leakage, and helps to ensure a better night's sleep for Obstructive Sleep Apnea patients.

26 Oct 2009

Continucare acquires two additional centers

Continucare Corporation (NYSE Amex:CNU) announced today that it has expanded its sleep diagnostic division with the acquisition of two additional centers. Seredor Corporation, Continucare’s newly established subsidiary, has purchased the assets of Sleep Disorder Solutions, Inc., a full service operator of sleep diagnostic centers, with sleep diagnostic centers in South Miami and Pembroke Pines, Florida.

23 Oct 2009

SNAP Diagnostics joins SAFE-BioPharma Association

SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.

22 Oct 2009

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.

22 Oct 2009

Diet and exercise program unlikely to eliminate OSA in overweight patients

A study in the Oct. 15 issue of the Journal of Clinical Sleep Medicine found that while a strict diet and exercise program may benefit obese patients with mild to moderate obstructive sleep apnea (OSA), it is unlikely to eliminate the condition.

15 Oct 2009

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Nearly all patients who underwent surgery to treat oropharyngeal cancer experienced some degree of obstructive sleep apnea (OSA), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

7 Oct 2009

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.

6 Oct 2009

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

From ResMed Corp 6 Oct 2009

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

Today, at the American Academy of Otolaryngology-Head and Neck Surgery annual meeting, ImThera Medical, Inc. unveiled its new product, the aura6000™ neurostimulation system for the treatment of Obstructive Sleep Apnea (OSA).

5 Oct 2009

GI tract conditions can occur in sleep apnea patients

Patients who suffer from obstructive sleep apnea (OSA) also tend to have additional gastrointestinal (GI) tract conditions, such as gastric reflux and hiatal hernia, which form at the opening in your diaphragm where your food pipe (esophagus) joins your stomach.

5 Oct 2009

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Patients who suffer from both allergic rhinitis and obstructive sleep apnea (OSA) may experience escalated symptoms of stress and fatigue.

5 Oct 2009

Radiofrequency ablation used to treat snoring patients

Radiofrequency ablation, a procedure that uses heat to shrink the tissue of the soft palate, is an effective and minimally invasive procedure that can be used to treat patients who snore.

5 Oct 2009

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

ImThera Medical, Inc. has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat Obstructive Sleep Apnea (OSA). Along with the clinical trial approvals, ImThera has received ISO 13485 certification of its quality system as a pre-requisite for the future CE mark application for European commercialization of medical products.

1 Oct 2009

FDA grants priority review for Cephalon's sNDA

Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.

25 Sep 2009

ImThera Medical completes THN system development

ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

24 Sep 2009

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

22 Sep 2009

Cardiac MRI exams gain prominence in the medical imaging market

Developments in imaging technology and software continue to help cardiac MRI exams gain prominence in the medical imaging market by meeting the demand for faster scan times and the ability to view areas of the body that were previously deemed impossible to image, according to "Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound" by healthcare market research firm Kalorama Information.

16 Sep 2009

Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy

A study in the Aug. 1 issue of the journal SLEEP indicates that children have an increased risk of developing obstructive sleep apnea (OSA) if they have at least one sibling who has been diagnosed with the sleep disorder.

3 Aug 2009

Severe obesity brings greater risks of health problems during medical procedures

Healthcare providers must carefully consider the unique risk factors related to severe obesity in patients undergoing all types of surgery, according to an American Heart Association scientific advisory published in Circulation: Journal of the American Heart Association.

15 Jun 2009

Prevalence of type 2 diabetes in patients with obstructive sleep apnea

A multi-ethnic study in the June 15 issue of the Journal of Clinical Sleep Medicine reports that there is a statistically significant relationship between obstructive sleep apnea (OSA) episodes occurring during rapid eye movement (REM) sleep and type 2 diabetes.

15 Jun 2009

Obstructive Sleep Apnea News and Research

Further Reading

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Continucare acquires two additional centers

SNAP Diagnostics joins SAFE-BioPharma Association

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

Diet and exercise program unlikely to eliminate OSA in overweight patients

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

ResMed announces acquisition of Laboratoires Narval

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

GI tract conditions can occur in sleep apnea patients

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Radiofrequency ablation used to treat snoring patients

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

FDA grants priority review for Cephalon's sNDA

ImThera Medical completes THN system development

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Cardiac MRI exams gain prominence in the medical imaging market

Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy

Severe obesity brings greater risks of health problems during medical procedures

Prevalence of type 2 diabetes in patients with obstructive sleep apnea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News